Wikiwand AI

Carboxypeptidase A6

Protein-coding gene in the species Homo sapiens From Wikipedia, the free encyclopedia

Carboxypeptidase A6 (CPA6) is a metallocarboxypeptidase enzyme that in humans is encoded by the CPA6 gene.[5]

AliasesCPA6, CPAH, ETL5, FEB11, carboxypeptidase A6
External IDsOMIM: 609562; MGI: 3045348; GeneCards: CPA6
End67,746,378 bp[1]
Quick facts CPA6, Identifiers ...
CPA6
Identifiers
AliasesCPA6, CPAH, ETL5, FEB11, carboxypeptidase A6
External IDsOMIM: 609562; MGI: 3045348; GeneCards: CPA6
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001127445
NM_020361

NM_001289497
NM_177834

RefSeq (protein)

NP_065094

NP_001276426
NP_808502

Location (UCSC)Chr 8: 67.42 – 67.75 MbChr 1: 10.39 – 10.79 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Close

Tissue distribution

It is highly expressed in the adult mouse olfactory bulb and is broadly expressed in the embryonic brain and other tissues.[6]

Function

The protein encoded by this gene belongs to the family of carboxypeptidases, which catalyze the release of C-terminal amino acid, and have functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides.[5]

CPA6 processes several neuropeptides, including [Met]- and [Leu]-enkephalin, angiotensin I, and neurotensin in vitro.[6] Whereas CPA6 is capable of converting the enkephalins and neurotensin into inactive forms, it can convert the inactive angiotensin I into the active angiotensin II.[6] CPA6 may have additional roles in processing peptides and proteins in vivo, but the nature of these substrates and the effects of these cleavages are currently unknown.

Clinical significance

Polymorphic variants and a reciprocal translocation t(6;8)(q26;q13) involving this gene, have been associated with Duane retraction syndrome.[5]

See also

References

Further reading

Related Articles

Timelines

Top Qs

Fact Checks